Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

Université Laval

$25,000.00

Synthesis of Chromophore-Containing hydrosoluble dendrimers biomedical applications

FY 2014-15

Summary
Klox Technologies, a Canada-based company, is seeking at developing new molecular tools to carrychromophores under the skin surface. Their present technology involves complex formulations includingbiocompatible polymers and chromophores capable of doing oxygen sensitization to treat skin diseases. Theobjective of this research proposal is to attach chromophores to new organic materials that will allow thedelivery of the chromophores under the skin surface. The materials we intend to develop are based on acombination of ethylene-oxide and triazole called PEOT. The PEOT is advantageous since it can be easilyprepared in multigrams scale without the use of metal, which is a necessary requirement for the pharmaceuticalindustry. Moreover, PEOT moiety is know to be non-toxic and biocompatible. Finally, PEOT can be madehighly water-soluble, which is an important factor for the preparation of hydrogels for skin applications. Thematerials will be developed in Prof. Morin's laboratory while the testing will be accomplished at KloxTechnologies. Because of the nature of this project and Klox expertise with this type materials, it is very likelythat the technology we will develop in this project will be use rapidly by the company to improve their currenttechnologies. Hence, Klox Technologies will gain an undisputable edge over their competitors in the area ofskin disease treatments. Considering that pharmaceutical industry is a strong economic player, all newdevelopments allowing improvement of their current technologies is advantageous for Canada. As the newlydeveloped materials are very likely to be promising, this project will create the need for additional highlyqualified personal (HQP) at Klox Technologies.
Program
Engage Grants Program
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
476550-2014
Name nom
Morin, JeanFrancois
Department département
Chimie
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3750
Research subject group en
Polymer chemistry
Research subject group fr
Chimie des polymères
Research subject en
Polymer chemistry
Research subject fr
Chimie des polymères
Partie
1
Nb partie
1
Application title
Synthesis of Chromophore-Containing hydrosoluble dendrimers biomedical applications
Keyword
NSERC
Application summary
Klox Technologies, a Canada-based company, is seeking at developing new molecular tools to carrychromophores under the skin surface. Their present technology involves complex formulations includingbiocompatible polymers and chromophores capable of doing oxygen sensitization to treat skin diseases. Theobjective of this research proposal is to attach chromophores to new organic materials that will allow thedelivery of the chromophores under the skin surface. The materials we intend to develop are based on acombination of ethylene-oxide and triazole called PEOT. The PEOT is advantageous since it can be easilyprepared in multigrams scale without the use of metal, which is a necessary requirement for the pharmaceuticalindustry. Moreover, PEOT moiety is know to be non-toxic and biocompatible. Finally, PEOT can be madehighly water-soluble, which is an important factor for the preparation of hydrogels for skin applications. Thematerials will be developed in Prof. Morin's laboratory while the testing will be accomplished at KloxTechnologies. Because of the nature of this project and Klox expertise with this type materials, it is very likelythat the technology we will develop in this project will be use rapidly by the company to improve their currenttechnologies. Hence, Klox Technologies will gain an undisputable edge over their competitors in the area ofskin disease treatments. Considering that pharmaceutical industry is a strong economic player, all newdevelopments allowing improvement of their current technologies is advantageous for Canada. As the newlydeveloped materials are very likely to be promising, this project will create the need for additional highlyqualified personal (HQP) at Klox Technologies.